- Home
- SRDX vs CHPT Comparison
SRDX vs CHPT Comparison
Compare SRDX & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRDX
- CHPT
- Stock Information
- Founded
- SRDX 1979
- CHPT 2007
- Country
- SRDX United States
- CHPT United States
- Employees
- SRDX N/A
- CHPT N/A
- Industry
- SRDX Medical/Dental Instruments
- CHPT Industrial Specialties
- Sector
- SRDX Health Care
- CHPT Consumer Discretionary
- Exchange
- SRDX Nasdaq
- CHPT Nasdaq
- Market Cap
- SRDX 402.2M
- CHPT 256.9M
- IPO Year
- SRDX 1998
- CHPT N/A
- Fundamental
- Price
- SRDX $27.29
- CHPT $11.08
- Analyst Decision
- SRDX Buy
- CHPT Hold
- Analyst Count
- SRDX 3
- CHPT 11
- Target Price
- SRDX $43.00
- CHPT $18.40
- AVG Volume (30 Days)
- SRDX 99.0K
- CHPT 478.3K
- Earning Date
- SRDX 11-10-2025
- CHPT 12-03-2025
- Dividend Yield
- SRDX N/A
- CHPT N/A
- EPS Growth
- SRDX N/A
- CHPT N/A
- EPS
- SRDX N/A
- CHPT N/A
- Revenue
- SRDX $120,801,000.00
- CHPT $397,731,000.00
- Revenue This Year
- SRDX N/A
- CHPT N/A
- Revenue Next Year
- SRDX $3.38
- CHPT $12.63
- P/E Ratio
- SRDX N/A
- CHPT N/A
- Revenue Growth
- SRDX N/A
- CHPT N/A
- 52 Week Low
- SRDX $26.00
- CHPT $8.55
- 52 Week High
- SRDX $40.39
- CHPT $30.00
- Technical
- Relative Strength Index (RSI)
- SRDX 26.65
- CHPT 49.94
- Support Level
- SRDX $26.78
- CHPT $10.48
- Resistance Level
- SRDX $28.69
- CHPT $11.35
- Average True Range (ATR)
- SRDX 0.67
- CHPT 0.68
- MACD
- SRDX 0.07
- CHPT -0.15
- Stochastic Oscillator
- SRDX 23.15
- CHPT 30.10
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.